Showing results (101-110 of 142) with videos related to
Sort By:
Pageof 15
Biochemical Pharmacology|July 19, 1994
Reversal of P-glycoprotein-mediated multidrug resistance by pure anti-oestrogens and novel tamoxifen derivativesJ Kirk, S K Syed, A L Harris, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1984
Metabolism of aminoglutethimide in humans. Identification of four new urinary metabolitesA B Foster, L J Griggs, I Howe, et al.British Journal of Haematology|August 8, 1998
Inhibitory effect of simvastatin on the proliferation of human myeloid leukaemia cells in severe combined immunodeficient (SCID) miceR D Clutterbuck, B C Millar, R L Powles, et al.Journal of Enzyme Inhibition|January 1, 1992
Effects of 4-hydroxyandrost-4-ene-3,17-dione and its metabolites on 5 alpha-reductase activity and the androgen receptorJ H Davies, R J Shearer, M G Rowlands, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1993
Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patientsG K Poon, Y C Chui, R McCague, et al.Biomedical Mass Spectrometry|October 1, 1984
Metabolism of 1,1,1,2,2-pentafluorohexane and 1,1-difluorocyclohexane by rat liver microsomes in vitroM H Baker, A B Foster, L Hegedus, et al.Biochemical Pharmacology|May 11, 1995
The role of the N-(hydroxymethyl)melamines as antitumour agents: mechanism of action studiesH M Coley, N Brooks, D H Phillips, et al.Journal of Hospital Medicine|July 17, 2010
A descriptive case series of patients with end-stage liver disease hospitalized with variceal bleeding who received pharmacologic venous thromboembolism prophylaxisAnneliese M Schleyer, Mark W Smith, Kenneth M Jarman, et al.Journal of Medicinal Chemistry|August 16, 1996
3- and 4-pyridylalkyl adamantanecarboxylates: inhibitors of human cytochrome P450(17 alpha) (17 alpha-hydroxylase/C17,20-lyase). Potential nonsteroidal agents for the treatment of prostatic cancerF C Chan, G A Potter, S E Barrie, et al.Lancet (London, England)|December 18, 1993
Acquired tamoxifen resistance in human breast cancer and reduced intra-tumoral drug concentrationS R Johnston, B P Haynes, I E Smith, et al.Pageof 15